<?xml version="1.0" encoding="UTF-8"?>
<xml>
 <records>
  <record>
   <ref-type name="Journal Article">17</ref-type>
   <contributors>
    <authors>
     <author></author>
     <author></author>
     <author></author>
     <author></author>
     <author></author>
     <author></author>
     <author></author>
     <author></author>
     <author></author>
     <author></author>
    </authors>
   </contributors>
   <titles>
    <title></title>
   </titles>
   <dates>
    <year>2021</year>
    <pub-dates>
     <date>2021-12-14</date>
    </pub-dates>
   </dates>
   <doi>10.1007/s11094-021-02491-0</doi>
   <abstract>The development and optimization of synthetic methods for alkyl esters of 4-[(1H-azol-1-yl)methyl]phenols enabled the expansion of organic synthesis methodology, which is extremely important for designing new structures with various types of biological activity, e.g., antiaggregant and anticoagulant. The present work studied O-alkylation of 4-[(1H-azol-1-yl)methyl]phenols with various alkylating agents, e.g., n-octyl bromide, n-hexadecyl bromide, and (adamantyl-1)bromomethylketone. The newly synthesized compounds were identified using elemental analysis and IR and PMR spectroscopy. Laboratory studies of blood isolated from healthy volunteers revealed compounds with antiaggregant and anticoagulant properties.</abstract>
   <urls>
    <web-urls>
     <url>https://repo.bashgmu.ru/publication/2058</url>
    </web-urls>
    <pdf-urls>
     <url>https://repo.bashgmu.ru/files/2230</url>
    </pdf-urls>
   </urls>
  </record>
 </records>
</xml>
